Clinical trials
Phase 3 Genetic Diseases, Inborn trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Quince Therapeutics S.p.A. | 2 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| NewAmsterdam Pharma | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 5 |
| Achondroplasia | 1 |
| Ataxia Telangiectasia | 1 |
| Bone Diseases | 1 |
| Dwarfism | 1 |
| Dyslipidemias | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipoproteinemia Type II | 1 |
| Hyperlipoproteinemias | 1 |
| Hyperoxaluria, Primary | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.